JB
Highly rated in
27
conditions
Highly rated in
27
conditions
Check Dr. Jaishri O. Blakeley's experience treating your condition:
About Dr. Jaishri O. Blakeley

Jaishri Blakeley is a Neurologist in Baltimore, Maryland. Blakeley has been practicing medicine for over 21 years and is highly rated in 27 conditions, according to our data. Her top areas of expertise are Neurofibromatosis, Neurofibromatosis Type 1, Neurofibromatosis Type 2, and Schwannomatosis. She is licensed to treat patients in Maryland. Blakeley is currently accepting new patients.

Her clinical research consists of co-authoring 154 peer reviewed articles and participating in 9 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Jaishri O. Blakeley it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Jaishri O. Blakeley accepts the following insurance:

  •  Ambetter
  •  CareFirst

Call to see if your plan is accepted.
Locations
600 N Wolfe St, Baltimore, MD 21287
Other Locations
10753 Falls Rd, Timonium, MD 21093
Background & Education
Graduate Institution
Baylor College Of Medicine, 2001
Specialties
Neurology
Licenses
Psychiatry & Neurology in MD
Hospital Affiliations
The Johns Hopkins Hospital
Howard County General Hospital
Languages Spoken
English
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


9 Clinical Trials

Neoadjuvant Nivolumab Plus Ipilimumab for Newly Diagnosed Malignant Peripheral Nerve Sheath Tumor
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2 (INTUITT-NF2)
Exploration and Estimation of Intratumoral Concentration and Activity of Lapatinib in Vivo in Vestibular Schwannomas
The Feasibility and Biologic Effect of a Modified Atkins-based Intermittent Fasting Diet in Patients With Glioblastoma (GBM)
A Phase II Study of Cabozantinib (XL184) for Plexiform Neurofibromas in Subjects With Neurofibromatosis Type 1 in Children and Adults
Phase 2 Study of Bevacizumab in Children and Adults With Neurofibromatosis Type 2 and Symptomatic Vestibular Schwannoma
A Phase II Trial of Low Dose Fractionated Radiation Therapy as a Chemo-Potentiator of Salvage Temozolomide for Recurrent Anaplastic Astrocytoma and Glioblastoma Multiforme
View 6 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors